Highlights
- On June 14, 2023, FDA published a new version of the premarket software guidance document which replaces the 2005 version.
- The new final guidance takes a simplified risk-based approach to help determine the device's Documentation Level, which is either Basic or Enhanced.
- The newly recommended information outlined in this guidance will not be required during review of submissions received through August 13, 2023. CDRH does, hoewever, intend to review any such information if submitted.
Read the full guidance.
Software Documentation Elements | Basic Documentation Level | Enhanced Documentation Level |
Documentation Level Evaluation | Statement of Documentation Level and rationale |
Software Description | Overview of significant software features, functions, analyses, inputs, outputs, and hardware platforms |
Risk Management File | Risk management plan, assessment, and report. |
Software Requirements Specification (SRS) | SRS with sufficient information to understand traceability to risk management, SDS, architecture design, and testing. |
System and Software Architecture Design | Diagrams of the device modules, layers, and interfaces, their relationships, data flows, and user interactions. |
Software Design Specification (SDS) | N/A | SDS that details how the design implements and is traceable to the SRS |
Software Development, Configuration Management, and Maintenance Practices | Summary of the life cycle development plan, configuration management and maintenance activities OR Declaration of Conformity to IEC 62304 | Basic documentation PLUS complete configuration management and maintenance plan(s) OR Declaration of Conformity to IEC 62304 |
Software Testing as Part of Verification and Validation | Summary of unit, integration, and system testing. AND System level test protocol and report. | Basic documentation PLUS unit and integration level test protocols and reports. |
Software Version History | History of tested versions including date, version number, and change descriptions |
Unresolved Software Anomalies | List of software anomalies and evaluation of device’s safety and effectiveness. |
Related Guidance Update
The FDA intends to issue minor updates to the guidance Off-The-Shelf Software Use in Medical Devices as well as to certain device specific guidances to reflect and ensure consistency with the information conveyed within the final guidance.
Upcoming webinar on this guidance
On July 20, 2023, the FDA will host a webinar for medical device manufacturers and other stakeholders interested in learning more about the final guidance and the recommendations for documentation sponsors should include in premarket submissions.
Learn more about Qserve US Market Access services and schedule your free consultation to see how our experts can help bring into United States Market.